A single-arm clinical trial found minimal amelioration in both ASD-related behaviors and fecal microbiome diversity with 28 GR plus myrosinase tablets/day depending on body weight (36), and one study found no difference in behavioral measures between treatment and placebo groups with 50 mol/day (38)
Scans were taken every 3 h, with data collected up to 48 h
KLOW blend is intended for preclinical research only and for laboratory handling by scientific personnel operating under applicable institutional guidelines and established laboratory protocols
Raij T, Raij K
Light exposure during storage affects peptides stored in clear vials without protection
The distinctive characteristic of Ipamorelin is its exceptional SELECTIVITY: unlike other GHRPs (GHRP-6, GHRP-2, Hexarelin), Ipamorelin does NOT induce significant increases in prolactin, cortisol, ACTH, or aldosterone at studied therapeutic doses